These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15157565)

  • 1. The role and assessment of ventricular peptides in heart failure.
    Winter WE; Elin RJ
    Clin Lab Med; 2004 Mar; 24(1):235-74. PubMed ID: 15157565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of myocardial damage in acute decompensated heart failure: changing the paradigm from a passive to an active process.
    Perna ER; Címbaro Canella JP; Macin SM
    Minerva Cardioangiol; 2005 Dec; 53(6):523-35. PubMed ID: 16333236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides in the diagnosis and management of acute heart failure.
    Mohammed AA; Januzzi JL
    Heart Fail Clin; 2009 Oct; 5(4):489-500. PubMed ID: 19631174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides in heart failure: empathizing with the sobbing heart..
    Narula J; Young JB
    Heart Fail Clin; 2006 Jul; 2(3):xi-xiii. PubMed ID: 17386893
    [No Abstract]   [Full Text] [Related]  

  • 5. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of natriuretic peptides in heart failure patients with special reference to those on cardiac resynchronization therapy.
    Ricciardi G; Pieragnoli P; Colella A; Giaccardi M; Padeletti L; Abbate R; Gensini GF; Michelucci A
    Minerva Cardioangiol; 2006 Dec; 54(6):743-52. PubMed ID: 17167386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression.
    Gwechenberger M; Pacher R; Berger R; Zorn G; Moser P; Stanek B; Huelsmann M
    J Heart Lung Transplant; 2005 Dec; 24(12):2190-5. PubMed ID: 16364870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.
    Voors AA; Petrie CJ; Petrie MC; Charlesworth A; Hillege HL; Zijlstra F; McMurray JJ; van Veldhuisen DJ
    Eur Heart J; 2005 Sep; 26(17):1759-64. PubMed ID: 15833758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 10. Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department.
    Collins S; Storrow AB; Kirk JD; Pang PS; Diercks DB; Gheorghiade M
    Ann Emerg Med; 2008 Jan; 51(1):45-57. PubMed ID: 17868954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does measuring natriuretic peptides have a role in patients with chronic kidney disease?
    Hajjar V; Schreiber MJ
    Cleve Clin J Med; 2009 Aug; 76(8):476-8. PubMed ID: 19652041
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical biochemistry: heart hormones. The Danish Society of Biochemistry].
    Gøtze JP; Rehfeld JF
    Ugeskr Laeger; 2004 Mar; 166(12):1109. PubMed ID: 15067768
    [No Abstract]   [Full Text] [Related]  

  • 13. [Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].
    Hradec J; Krupicka J; Janota T
    Cas Lek Cesk; 2009; 148(8):383-8. PubMed ID: 19899725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides and the heart: current and future implications for clinical biochemistry.
    Penney MD
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):432-40. PubMed ID: 16259793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we IMPROVE-CHF management by measuring natriuretic peptides?
    Greenberg B
    Circulation; 2007 Jun; 115(24):3045-7. PubMed ID: 17576881
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
    Dahlström U
    Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945
    [No Abstract]   [Full Text] [Related]  

  • 20. Natriuretic peptides as a prognostic marker and therapeutic target in heart failure.
    Wright GA; Struthers AD
    Heart; 2006 Feb; 92(2):149-51. PubMed ID: 16216866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.